AI-Generated Filing Summaries

Revenue grew 8.9% year-over-year to $78.4 million, driven by positive impacts from sales volume and price, which management highlights as a key focus area for evaluating performance.

Gross profit increased 6.7% to $41.5 million, with a gross margin of 52.9%, as the company benefited from pricing and volume dynamics that positively impacted margin.

Operating loss deepened by 29.8% to -$13.0 million, and net loss widened by 83.4% to -$8.1 million, indicating that revenue gains were overshadowed by significant expense pressures.

CWCapital Asset Management LLC was terminated as special servicer for The Veranda and Audubon Crossings & Commons loan combinations effective April 2, 2025.

Torchlight Loan Services, LLC was appointed as the successor special servicer for the affected loan combinations under the BMARK 2021-B30 PSA.

LMCG Investments, LLC, as Directing Holder, executed the termination and appointment pursuant to Sections 3.22(b) and 7.02 of the PSA.

The registrant sold Units of Beneficial Interest in an unregistered offering on March 31, 2026, raising $2.06 million in aggregate cash consideration.

The offering was conducted privately under Regulation D, relying on an exemption from registration under Section 4(2) of the Securities Act.

Philippe Pradel was promoted to Chief Compliance Officer and Deputy General Counsel of Campbell & Company, LP, effective March 30, 2026.

Issued four new consolidated obligations with a total principal amount of $1.51 billion across trade dates March 30-31, 2026.

Three obligations are short-term variable rate discount notes maturing in July-August 2026, totaling $1.5 billion.

One obligation is a longer-term fixed rate bond maturing in April 2029 with a 4.23% coupon and optional redemption features.

The company purchased 9,499,296 of its ordinary shares on April 2, 2026.

The share purchases were executed by Goldman Sachs International as broker.

The highest price paid per share was 97.4600 pence, with a volume weighted average price of 96.6426 pence.

The company purchased 9,499,296 of its ordinary shares on April 2, 2026.

The share purchases were executed by Goldman Sachs International as broker.

The highest price paid per share was 97.4600 pence, with a volume weighted average price of 96.6426 pence.

The company purchased 9,499,296 of its ordinary shares on April 2, 2026.

The share purchases were executed by Goldman Sachs International as broker.

The highest price paid per share was 97.4600 pence, with a volume weighted average price of 96.6426 pence.

Operating income was -$542.6K, reflecting formation, professional, and administrative costs required to maintain public company status and pursue acquisition targets—no operating revenue was generated, as expected prior to business combination.

Net income was $320.6K, attributable entirely to non-operating interest income on trust and cash holdings, per management’s disclosure that the company generates no operating revenue until after a business combination.

Diluted EPS was -$0.78, resulting from dilution by outstanding rights and the absence of earnings power—this metric reflects accounting mechanics rather than operational performance.

Operating income was -$542.6K, reflecting formation, professional, and administrative costs required to maintain public company status and pursue acquisition targets—no operating revenue was generated, as expected prior to business combination.

Net income was $320.6K, attributable entirely to non-operating interest income on trust and cash holdings, per management’s disclosure that the company generates no operating revenue until after a business combination.

Diluted EPS was -$0.78, resulting from dilution by outstanding rights and the absence of earnings power—this metric reflects accounting mechanics rather than operational performance.

Operating income was -$542.6K, reflecting formation, professional, and administrative costs required to maintain public company status and pursue acquisition targets—no operating revenue was generated, as expected prior to business combination.

Net income was $320.6K, attributable entirely to non-operating interest income on trust and cash holdings, per management’s disclosure that the company generates no operating revenue until after a business combination.

Diluted EPS was -$0.78, resulting from dilution by outstanding rights and the absence of earnings power—this metric reflects accounting mechanics rather than operational performance.

Gross profit increased to $8.7 million for FY2025 from $3.9 million in FY2024, reflecting improved operational efficiency in refinery operations.

Net loss narrowed to $5.6 million ($0.38 per share) in FY2025 from $8.6 million ($0.58 per share) in FY2024, indicating reduced losses despite continued unprofitability.

Consolidated EBITDA turned positive at $1.3 million in FY2025 versus $(1.5) million in FY2024, driven by refinery operations EBITDA of $2.9 million compared to $(0.4) million.

Revenue was $73.5K (-43.2% YoY), reflecting the timing of royalty income recognition under ASC 606 rather than organic business change.

Operating income was $22.9K (-55.3% YoY), consistent with the revenue decline and supported by ongoing reductions in accounting services, SEC filing fees, and elimination of insurance.

Net income was $22.9K (-55.1% YoY), aligning with operating income as no material non-operating items were reported.

Purchased 208,535 Ordinary Shares on 30 March 2026 on LSE at a volume-weighted average price of 542.7442 GBp — reduces outstanding share count and supports EPS accretion.

Purchased 222,743 Ordinary Shares on 30 March 2026 on BATE at a volume-weighted average price of 542.6705 GBp — confirms execution across multiple UK trading venues.

Purchased 153,802 Ordinary Shares on 31 March 2026 on LSE at a volume-weighted average price of 549.8374 GBp — highest VWAP of the week, reflecting tighter bid-ask spread near month-end.

Purchased 208,535 Ordinary Shares on 30 March 2026 on LSE at a volume-weighted average price of 542.7442 GBp — reduces outstanding share count and supports EPS accretion.

Purchased 222,743 Ordinary Shares on 30 March 2026 on BATE at a volume-weighted average price of 542.6705 GBp — confirms execution across multiple UK trading venues.

Purchased 153,802 Ordinary Shares on 31 March 2026 on LSE at a volume-weighted average price of 549.8374 GBp — highest VWAP of the week, reflecting tighter bid-ask spread near month-end.

Dividend Committee declared quarterly dividend of $0.49091 per share on March 30, 2026.

Record date: close of business on March 27, 2026.

Payment date: on or about April 22, 2026.

Monthly cash distribution declared at $0.324970 per unit, payable April 29, 2026 to record holders as of April 15, 2026.

Distribution reflects oil production for January 2026 and gas production for December 2025, with preliminary volumes of 44,645 barrels of oil and 885,409 Mcf of gas.

Preliminary average prices were $57.57 per barrel of oil and $3.42 per Mcf of gas for the current month.

First quarter 2026 financial results will be released after market close on April 29, 2026.

A conference call to discuss results will be held on April 30, 2026 at 11:00 am ET.

The 2026 Annual General Meeting of Shareholders will be held virtually on May 28, 2026 at 11:00 am ET.

Revenue increased 505.5% to $8.7M, reflecting a significant expansion in business activity compared to the prior year.

Gross profit grew 333.4% to $2.6M, resulting in a gross margin of 29.5%, an improvement from the prior year's levels.

Net cash used in operating activities was $521,734, a shift from $3.25M provided in the prior year, reflecting cash usage during the business transition.

CWCapital Asset Management LLC was removed as special servicer for the 520 Almanor Mortgage Loan.

Torchlight Loan Services, LLC was appointed as the successor special servicer.

The servicing change is effective as of April 2, 2026.

CWCAM replaces LNR Partners, LLC as special servicer for the 685 Fifth Avenue Retail Non-Serviced Loan Combination effective April 2, 2026.

The appointment was made by RX IV CMBS, LP, the directing certificateholder under the BANK 2018-BNK15 PSA.

CWCAM will assume responsibilities for servicing and administration if the loan becomes specially serviced, including any related REO property.

Amended option grant for CFO Brian Meadows to purchase 750,000 shares originally granted September 9, 2025.

Removed original milestone conditions from the stock options.

New vesting: one-third annually on each anniversary of March 27, 2026, contingent on continued employment.

The Bank issued $5.7 billion in consolidated obligation bonds across seven separate tranches with trade dates between March 30 and March 31, 2026.

All issued instruments are Variable Single Index Floaters with Non-Callable provisions and unspecified coupon percentages.

Maturity dates are short-term, ranging from July 2, 2026, to December 8, 2026, indicating near-term liquidity management.

Boliden completed its $30 million earn-in investment to secure a 60% interest in the DUKE District Joint Venture, effective April 1, 2026 — confirming continued major partner commitment and de-risking near-term exploration funding.

Boliden elected not to exercise its option to increase its interest to 70% by investing an additional $60 million — indicating strategic prioritization of capital allocation and potential moderation of long-term exposure.

The DUKE JV will fund future exploration on a pro rata 60% (Boliden) / 40% (Amarc) basis, with dilution rights — introducing potential for equity realignment based on future spending decisions.

CWCapital Asset Management LLC was removed as special servicer for the Benchmark 2021-B30 Mortgage Trust.

Torchlight Loan Services, LLC was appointed as the successor special servicer, effective April 2, 2026.

Torchlight is a Delaware LLC with experience servicing CMBS assets since 2007 and has resolved over $12.2 billion in loans.

2025 Annual Compliance Reports under section 13G(2) of Broad-Based Black Economic Empowerment Amendment Act published.

2025 B-BBEE Certificate made available on company website.

Compliance fulfills JSE Limited Listings Requirements paragraph 12.7(g) with Appendix 1 to Section 6.

2025 Annual Compliance Reports under section 13G(2) of Broad-Based Black Economic Empowerment Amendment Act published.

2025 B-BBEE Certificate made available on company website.

Compliance fulfills JSE Limited Listings Requirements paragraph 12.7(g) with Appendix 1 to Section 6.

Orion Digital Corp. issued 2025 AIF for fiscal year ended December 31, 2025.

AIF dated March 31, 2026, with information stated as of December 31, 2025.

David Feller (CEO) and Gregory Feller (CFO) certified no material misrepresentations and fair presentation of financial condition.

Orion Digital Corp. issued 2025 AIF for fiscal year ended December 31, 2025.

AIF dated March 31, 2026, with information stated as of December 31, 2025.

David Feller (CEO) and Gregory Feller (CFO) certified no material misrepresentations and fair presentation of financial condition.

The company is a SPAC with no operating history, targeting a business combination within 18 months — this defines its entire business model and risk profile.

It will not pursue targets based in or operating in the PRC due to regulatory uncertainty, materially narrowing its target universe and increasing competitive pressure.

The offering consists of 6,000,000 units at $10.00 each (up to 6,900,000 if the over-allotment option is exercised), each unit comprising one Class A ordinary share and one right for 1/7 of a share.

Rennova Health, Inc. — controlled by FOXO’s CEO — holds ~97.59% of voting rights as of March 20, 2026, enabling unilateral approval of corporate actions.

The Majority Stockholder approved a 150% increase in authorized Class A Common Stock, from 10B to 25B shares, via written consent without a shareholder meeting.

The Board fixed March 20, 2026 as the record date for determining stockholders entitled to receive the Schedule 14C Information Statement.